Fortis Malar Hospitals Ltd vs Jupiter Life Line Hospitals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Fortis Malar Hospitals Ltd is ₹ 40.21 as of 23 Oct 15:30 . The P/E Ratio of Fortis Malar Hospitals Ltd changed from 1.9 on March 2024 to 18.9 on March 2026 . This represents a CAGR of 115.06% over 3 yearsThe P/E Ratio of Jupiter Life Line Hospitals Ltd changed from 44.5 on March 2024 to 43 on March 2026 . This represents a CAGR of -1.14% over 3 years The Market Cap of Fortis Malar Hospitals Ltd changed from ₹ 103.92 crore on March 2021 to ₹ 78.13 crore on March 2026 . This represents a CAGR of -4.64% over 6 yearsThe Market Cap of Jupiter Life Line Hospitals Ltd changed from ₹ 7853 crore on March 2024 to ₹ 8344 crore on March 2026 . This represents a CAGR of 2.04% over 3 years The revenue of Fortis Malar Hospitals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 revenue of ₹ 0.54 crore. This represent the decline of -100% The revenue of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 467.04 crore as compare to the Jun '26 revenue of ₹ 421.57 crore. This represent the growth of 10.79% The ebitda of Fortis Malar Hospitals Ltd for the Sep '26 is ₹ 0 crore as compare to the Jun '26 ebitda of ₹ 0.2 crore. This represent the decline of -100% The ebitda of Jupiter Life Line Hospitals Ltd for the Sep '26 is ₹ 117.39 crore as compare to the Jun '26 ebitda of ₹ 89.86 crore. This represent the growth of 30.64% The net profit of Fortis Malar Hospitals Ltd changed from ₹ -0.06 crore to ₹ 0 crore over 10 quarters. This represents a CAGR of -100.00% The net profit of Jupiter Life Line Hospitals Ltd changed from ₹ 44.61 crore to ₹ 56.36 crore over 10 quarters. This represents a CAGR of 9.80% The Dividend Payout of Fortis Malar Hospitals Ltd changed from 168.63 % on March 2024 to 0 % on March 2026 . This represents a CAGR of -100.00% over 3 yearsThe Dividend Payout of Jupiter Life Line Hospitals Ltd changed from 4.32 % on March 2024 to 3.43 % on March 2026 . This represents a CAGR of -7.40% over 3 years .

About Fortis Malar Hospitals Ltd

Fortis Malar Hospital Limited, formerly known as Malar Hospital Limited was established on April 12, 1989 to set up, manage and operate a multi-specialty hospital.
Company is a subsidiary of Fortis Hospitals Limited and Fortis Healthcare Limited is the Intermediate Holding Company.
Later, the Company changed its name to 'Fortis Malar Hospital Limited' on December 21, 2010.
The Hospital building was owned by a fellow subsidiary, Fortis Health Management Limited (FHML) in early 2008. The hospital founded in 1989, has established itself as one of the largest corporate hospitals in Chennai, providing quality super specialty and multi-speciality healthcare services.
With a total bed-strength of 160, including 40 ICU/CCU/RTU beds, the hospital focuses on providing comprehensive medical care in the areas of Cardiology and Cardiac Surgery, Neuro Surgery, Gynaecology, Orthopedics, Gastroenterology, Neurology, Pediatrics, Diabetics, Nephrology and Internal Medicine All the above departments are fully became operational under phase I of the project.

About Jupiter Life Line Hospitals Ltd

Jupiter Life Line Hospitals Limited was incorporated in Mumbai, Maharashtra through a Certificate of Incorporation dated November 18, 2002, issued by the RoC, which subsequently, commenced its business operations in December, 2002.
Led by founding Promoter, Dr. Ajay Thakker, the Company is a prominent multi-speciality tertiary and quaternary healthcare service provider in the Mumbai metropolitan area and Western India with total operational bed capacity of 1,194 across three hospitals located in Thane, Pune and Indore under the 'Jupiter' brand.
The Company is constructing a new multi-speciality hospital in Dombivali, Maharashtra with potential capacity of 500 beds.
The Company is also running Fortune Park Lake City Hotel in Thane for promoting medical tourism. The Company follow a patient first' ideology by creating the best infrastructure, technology and support to put the patient first and foremost and be futuristic and innovative in delivery of healthcare.

FAQs for the comparison of Fortis Malar Hospitals Ltd and Jupiter Life Line Hospitals Ltd

Which company has a larger market capitalization, Fortis Malar Hospitals Ltd or Jupiter Life Line Hospitals Ltd?

Market cap of Fortis Malar Hospitals Ltd is 75 Cr while Market cap of Jupiter Life Line Hospitals Ltd is 8,007 Cr

What are the key factors driving the stock performance of Fortis Malar Hospitals Ltd and Jupiter Life Line Hospitals Ltd?

The stock performance of Fortis Malar Hospitals Ltd and Jupiter Life Line Hospitals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Fortis Malar Hospitals Ltd and Jupiter Life Line Hospitals Ltd?

As of October 25, 2026, the Fortis Malar Hospitals Ltd stock price is INR ₹40.21. On the other hand, Jupiter Life Line Hospitals Ltd stock price is INR ₹244.25.

How do dividend payouts of Fortis Malar Hospitals Ltd and Jupiter Life Line Hospitals Ltd compare?

To compare the dividend payouts of Fortis Malar Hospitals Ltd and Jupiter Life Line Hospitals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.